ULK3 Supports Autophagy and Survival of Multiple Myeloma Cells
Multiple myeloma has long challenged researchers because the disease is not driven only by uncontrolled growth. Its malignant plasma cells ...
Tag: Multiple Myeloma
Expanding Options, New Questions in Early Relapsed or Refractory Multiple Myeloma Care
Multiple myeloma is entering an era of unprecedented therapeutic choice—and equally unprecedented uncertainty. A new clinical perspective by C.R. Tan ...
Mayo Clinic study finds no survival benefit from longer multiple myeloma maintenance therapy
Rochester, Minn. — A major U.S.-led cooperative group clinical trial coordinated by Mayo Clinic researchers has found that extending maintenance ...
ECOG-ACRIN ENDURANCE Trial Publishes Randomized Evidence on Lenalidomide Maintenance Duration in Multiple Myeloma
A landmark phase 3 trial in newly diagnosed multiple myeloma challenges a long-standing standard: indefinite lenalidomide maintenance. For patients who ...
Exploring How Pomalidomide Enhances Immune Response in the Battle Against Multiple Myeloma
Pomalidomide (POM) has emerged as a pivotal agent in the treatment landscape for multiple myeloma, a malignancy that significantly compromises ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!